G1 Therapeutics Total Assets (Quarterly) Analysis

G1 Therapeutics Inc (GTHX)

4.44 +0.31 (+7.51%) USD | NASDAQ | May 02, 16:00

4.48 +0.04 (+0.90%) Pre-Market: 09:15

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
December 31, 2023	121.54M
September 30, 2023	133.10M
June 30, 2023	147.89M
March 31, 2023	161.96M
December 31, 2022	187.96M
September 30, 2022	166.57M
June 30, 2022	186.88M
March 31, 2022	218.24M
December 31, 2021	254.09M
September 30, 2021	243.50M
June 30, 2021	276.76M
March 31, 2021	308.56M
December 31, 2020	228.55M
September 30, 2020	258.23M
June 30, 2020	253.60M

Date	Value
March 31, 2020	256.51M
December 31, 2019	284.83M
September 30, 2019	317.19M
June 30, 2019	331.65M
March 31, 2019	351.68M
December 31, 2018	371.27M
September 30, 2018	393.02M
June 30, 2018	190.60M
March 31, 2018	195.74M
December 31, 2017	105.17M
September 30, 2017	119.55M
June 30, 2017	134.10M
March 31, 2017	39.29M
December 31, 2016	48.21M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

121.54M

Minimum

Dec 2023

331.65M

Maximum

Jun 2019

228.30M

Average

243.50M

Median

Sep 2021

Total Assets (Quarterly) Benchmarks

Amicus Therapeutics Inc	777.88M
Geron Corp	394.08M
Palatin Technologies Inc	13.55M
Oragenics Inc	4.966M
TG Therapeutics Inc	329.59M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	86.15M
Shareholders Equity (Quarterly)	35.39M
Debt to Equity Ratio	1.457
Current Ratio	3.868
Net Debt Paydown Yield	3.16%